Resources with keywords: packaging
This guidance applies to Filoviruses, Arenaviruses, Rift Valley fever virus, Crimean Congo HFV. This guidance also applies to other high-consequence diseases that require a specialized laboratory, are highly pathogenic, and have no vaccine or treatment currently available, like Nipah virus disease.
Quick reference guide adapted from the CDC Laboratory Training course for shipping Covid samples.
FDA issued a letter to clinical laboratory staff about a safety risk with using transport media and SARS-CoV-2 testing platforms that are not compatible.